Study guide
Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN
Key Takeaways Explain This Topic AI
Document fornix shortening and symblepharon; apparent quietness does not prove scarring has stopped.
Negative DIF does not exclude ocular MMP, and specimen transport must match the test.
Progressive ocular MMP commonly needs systemic immune control as well as local symptom relief.
Chronic SJS injury may be driven by lid keratinisation and mechanical trauma as well as tear deficiency.
Last updated: October 2026
Recognise progressive scarring
Cicatrising conjunctivitis means conjunctival inflammation with scarring. Its consequences include shortening of fornices, adhesions between bulbar and palpebral conjunctiva ( symblepharon ), lid malposition, tear deficiency, limbal failure and corneal damage. The patient may complain of irritation long before advanced adhesions are obvious. Examine and compare all fornices and document progression with photographs and measurements; a quiet-looking conjunctiva does not always mean that the disease has stopped.
The differential includes ocular mucous membrane pemphigoid, Stevens–Johnson syndrome/toxic epidermal necrolysis, chronic medication toxicity, chemical injury, trachoma, graft-versus-host disease and other inflammatory conditions. A focal unilateral process can suggest neoplasia or local injury. Review all topical drops, previous surgery and systemic mucosal symptoms. Do not label every shortened fornix as pemphigoid without considering competing causes.
Ocular mucous membrane pemphigoid
Mucous membrane pemphigoid (MMP) is an autoimmune blistering disorder targeting epithelial basement-membrane-zone structures. Ocular disease can be associated with oral, nasal, pharyngeal, genital or other mucosal involvement. Ask about painful oral lesions, swallowing difficulty and airway symptoms and involve the relevant specialists; airway disease can be serious even when the main presenting complaint is ocular irritation.
Conjunctival or other appropriate mucosal biopsy for direct immunofluorescence can show linear immunoreactant deposition along the basement membrane. Plan site and transport with the laboratory, avoiding the assumption that a formalin-fixed histology specimen can also provide a valid DIF result. A negative test does not exclude ocular MMP. Repeat or alternative-site investigation and exclusion of other causes may be necessary. The European S3 guideline specifically addresses immunopathology-negative ocular disease.
Topical lubricants and short courses of local anti-inflammatory treatment can improve symptoms but do not reliably prevent progressive immune-mediated scarring. Active progressive ocular MMP usually requires systemic immunomodulatory treatment with ophthalmology and dermatology/rheumatology coordination. Agent selection depends on severity, comorbidity and monitoring. Do not perform elective lid or surface reconstruction through uncontrolled inflammation when stabilisation is possible. Conversely, a threatened cornea may need protective measures urgently while systemic treatment is organised.
SJS and toxic epidermal necrolysis
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions, often associated with medication exposure. Systemic stabilisation, withdrawal of the suspected trigger and acute medical care take priority. Ocular severity does not perfectly track the percentage of skin involvement. Early ophthalmic examination must inspect lid margins, conjunctiva, fornices and corneal epithelium, including hidden defects and pseudomembranes.
Acute management aims to preserve epithelial surfaces and prevent adhesions. Appropriate lubrication, removal of damaging debris, carefully selected topical therapy and early specialist consideration of amniotic membrane are relevant. Membrane coverage must address the involved surfaces; a small central corneal device does not protect damaged lid margins or the entire fornix. Timing and technique depend on the actual epithelial injury, and membrane placement is not a substitute for systemic care.
In the chronic phase, lid-margin keratinisation, trichiasis, dry eye, symblepharon and limbal stem-cell failure may mechanically damage the cornea. Treat the driver rather than escalating lubricants alone. Selected management includes mucous-membrane grafting, lash or lid repair, scleral devices and surface reconstruction, each with its own infection and healing risks. A clear graft placed in a severely dry, keratinised and inflamed environment has poor prospects unless those problems are addressed.
Distinguishing mechanism and stage
Feature Ocular MMP SJS/TEN-associated disease
Typical course Chronic progressive immune-mediated scarring Acute mucocutaneous episode followed by variable chronic damage
Diagnostic evidence Clinical phenotype plus DIF/serology and exclusion of mimics History and systemic/ocular features of the acute reaction
Major ongoing driver Active inflammation and fibrosis Residual surface failure, keratinisation, lid trauma and sometimes inflammation
Key management question Is systemic immune control adequate? Which damaged surface or lid structure is driving current injury?
These distinctions are useful but not absolute. A person with an old acute reaction can still have active inflammation, and a person with MMP can have severe mechanical damage after immune control. Assess both activity and accumulated structural injury at every visit.
A scarring case
An older adult using several glaucoma drops has bilateral irritation and shortened inferior fornices. Review the medication history, inspect upper fornices and oral mucosa, document scarring and seek specialist assessment. Medication-related pseudopemphigoid is a possibility, but stopping a suspected drop without an alternative pressure plan can harm the optic nerve. Arrange investigations and coordinate substitutions, then judge progression over time.
A patient recovering from SJS with a persistent corneal defect needs assessment of sensation, lid closure, lid-margin keratinisation, tear function and limbal status, as well as infection. Protective treatment can be urgent even if the systemic eruption has healed. The EBO external-disease syllabus includes these cicatrising disorders because preventing further scarring and rebuilding a viable surface are different clinical tasks.
Sections you finish are checked off in the contents.
- Up Next
- Dry eye, blepharitis and meibomian dysfunction
- Continue learning